Case Number 6727
Request Date 22/05/2019
Completion Date 17/06/2019

 

Details of the Request

Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between January and April 2019

If your trust is able to identify injections/implants by eye conditions please split by the drug used

  • ranibizumab,
  • bevacizumab,
  • aflibercept,
  • Fluocinolone and
  • Dexamethasone
  • Lucentis (ranibizumab) Injections
  • Avastin (bevacizumab) Injections
  • Eylea (aflibercept) Injections
  • Illuvien (Fluocinolone) Impants
  • Ozudex (Dexamethasone) Implants
  • TOTAL
  • Wet Age Related Macular Degeneration (wAMD)
  • Diabetic Macular Oedema (DMO)
  • Retinal Vein Occlusion - Central or Branch (CRVO or BRVO)
  • Other eg mCNV

 

Details of the Response

  Lucentis (Ranibizumab) Injections Avastin (Bevacizumab) Injections Eylea (Aflibercept) Injections Illuvien (Fluocinolone) Implants Ozudex (Dexamethasone) Implants
Wet Age Related Macular Degeneration (wAMD) 599 6 538 0 0
Diabetic Macular Oedema (DMO) 286 0 171 3 2
Retinal Vein Occlusion – Central or Branch (CRVO or BRVO) 101 0 83 0 7
Other: mCNV 2 0 4 0 0